MENU
+Compare
NUTX
Stock ticker: NASDAQ
AS OF
Nov 21 closing price
Price
$136.92
Change
-$5.42 (-3.81%)
Capitalization
968.29M

NUTX Nutex Health Inc. Forecast, Technical & Fundamental Analysis

Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division... Show more

NUTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for NUTX with price predictions
Nov 21, 2025

NUTX in -7.38% downward trend, sliding for three consecutive days on November 18, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where NUTX declined for three days, in of 255 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for NUTX moved out of overbought territory on October 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

NUTX broke above its upper Bollinger Band on November 20, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 62 cases where NUTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on November 20, 2025. You may want to consider a long position or call options on NUTX as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for NUTX just turned positive on November 21, 2025. Looking at past instances where NUTX's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

NUTX moved above its 50-day moving average on November 19, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +4 3-day Advance, the price is estimated to grow further. Considering data from situations where NUTX advanced for three days, in of 206 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 160 cases where NUTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NUTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.053) is normal, around the industry mean (8.273). P/E Ratio (6.682) is within average values for comparable stocks, (110.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.380). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.934) is also within normal values, averaging (1.299).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NUTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

View a ticker or compare two or three
NUTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Profile
Fundamentals
Details
Industry
N/A
Address
6030 S. Rice Ave
Phone
+1 713 660-0557
Employees
1030
Web
https://www.nutexhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MFRHX61.67N/A
N/A
MFS Research R3
IARCX16.30N/A
N/A
Invesco Real Estate C
RIEIX12.88N/A
N/A
RBC International Equity I
PQICX13.95N/A
N/A
PIMCO Dividend and Income C
MDDCX27.52-0.03
-0.11%
BlackRock Emerging Mkts Inv A

NUTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NUTX has been closely correlated with SMSI. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if NUTX jumps, then SMSI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUTX
1D Price
Change %
NUTX100%
-3.81%
SMSI - NUTX
87%
Closely correlated
+2.63%
DDI - NUTX
31%
Poorly correlated
+3.32%
VHC - NUTX
31%
Poorly correlated
-4.07%
SSNC - NUTX
27%
Poorly correlated
+1.45%
XBP - NUTX
27%
Poorly correlated
+5.65%
More

Groups containing NUTX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUTX
1D Price
Change %
NUTX100%
-3.81%
NUTX
(2 stocks)
100%
Closely correlated
-0.59%
Hospital/Nursing Management
(88 stocks)
31%
Poorly correlated
+1.09%
Health Services
(423 stocks)
-2%
Poorly correlated
+2.35%